- Home
- ADCT vs MED Comparison
ADCT vs MED Comparison
Compare ADCT & MED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- MED
- Stock Information
- Founded
- ADCT 2011
- MED 1980
- Country
- ADCT Switzerland
- MED United States
- Employees
- ADCT N/A
- MED N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- MED Packaged Foods
- Sector
- ADCT Health Care
- MED Consumer Staples
- Exchange
- ADCT Nasdaq
- MED Nasdaq
- Market Cap
- ADCT 131.8M
- MED 139.0M
- IPO Year
- ADCT 2020
- MED N/A
- Fundamental
- Price
- ADCT $1.21
- MED $11.92
- Analyst Decision
- ADCT Strong Buy
- MED Hold
- Analyst Count
- ADCT 5
- MED 1
- Target Price
- ADCT $7.75
- MED $16.50
- AVG Volume (30 Days)
- ADCT 373.9K
- MED 253.6K
- Earning Date
- ADCT 05-05-2025
- MED 04-28-2025
- Dividend Yield
- ADCT N/A
- MED N/A
- EPS Growth
- ADCT N/A
- MED N/A
- EPS
- ADCT N/A
- MED 0.19
- Revenue
- ADCT $70,837,000.00
- MED $602,463,000.00
- Revenue This Year
- ADCT $6.82
- MED N/A
- Revenue Next Year
- ADCT $18.56
- MED N/A
- P/E Ratio
- ADCT N/A
- MED $62.74
- Revenue Growth
- ADCT 1.84
- MED N/A
- 52 Week Low
- ADCT $1.05
- MED $11.88
- 52 Week High
- ADCT $5.17
- MED $36.30
- Technical
- Relative Strength Index (RSI)
- ADCT 39.36
- MED 32.66
- Support Level
- ADCT $1.13
- MED $11.88
- Resistance Level
- ADCT $1.25
- MED $13.54
- Average True Range (ATR)
- ADCT 0.11
- MED 0.64
- MACD
- ADCT 0.00
- MED -0.09
- Stochastic Oscillator
- ADCT 39.51
- MED 2.03
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.